Vir Biotechnology Inc at Goldman Sachs Healthcare Conference Transcript
Thank you very much. We'll continue with the next session. I'm Paul Choi, and I cover the small and mid-cap biotechnology sector here at Goldman Sachs. It's a great pleasure to welcome Vir for this session, and joining us is CEO, Marianne De Backer. We also have Phil Pang, CMO in the audience; and Sung Lee, CFO. What we'll do is some Q&A here and along the way, if you have questions, please e-mail us, and we'll be happy to read your questions anonymously.
Questions & Answers
Maybe what we'll start with, Marianne, is maybe some sort of high-level questions. Now that you've been in the CEO role for a little bit now. Can you maybe give us your initial impressions of the company? And what -- how you think about the strengths and weaknesses of the company you've joined here? And then what maybe programs or aspects excite you the most and inspire you to take on this role here?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |